A randomized, double-blind, placebo-controlled, multicenter, dose-range, proof-of-concept, 24-week treatment study of IVA337 in adult subjects with nonalcoholic steatohepatitis (NASH) (NATIVE)
10th July 2018 - ongoing
Status: Active
Specialism: Liver.
Team: Dr Stephen Ryder.
People
| Photo | Name | Bio |
|---|---|---|
 |
Dr Stephen Ryder |
Publications
| Title |
|---|
Grants
| Title | Amount |
|---|
